Session 1 | Industry 4.0, Big Data, AI, and Gene Editing
The convergence of digital and biotechnologies are allowing for astonishing rates of innovation that are addressing major global challenges. New tools such as Industry 4.0, Big Data, Artificial Intelligence, advances in Genome Editing and the opportunities for growth of R&D in these specific sectors in Latin America will be explored.
- Cristina Ropke, CEO, Phytobios
- John Murphy, Global VP R&D, Gene Therapy, Pfizer
- Marcia Dompieri, Researcher - Strategic Territorial Intelligence Group, Embrapa Satellite Monitoring
- Rafael Moreira, Secretary of Innovation and New Business, Brazilian Ministry of Industry, Foreign Trade and Services (MDIC)